InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Whitley Richard James, Director. Insider active across 2 companies, notably Gilead Sciences INC. In total, 9 filings have been logged. Total volume traded: €22k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€2,160500 shares@ €4.32079.7% of flow
Common Stock
SEC:0001415889-22-005275:0·
Ideal exit: 12 Feb 2023 (T+270)
€9,1011,800 shares@ €5.055990.0% of flow
Common Stock
SEC:0001415889-22-000447·
Ideal exit: 3 Oct 2022 (T+270)
€9,1011,800 shares@ €5.055940.7% of flow
Common Stock
SEC:0001415889-22-000447:0·
Ideal exit: 3 Oct 2022 (T+270)
€1,011200 shares@ €5.053510.0% of flow
Common Stock
SEC:0001415889-21-006204·
Ideal exit: 19 Sept 2022 (T+270)
€1,011200 shares@ €5.05354.5% of flow
Common Stock
SEC:0001415889-21-006204:0·
Ideal exit: 19 Sept 2022 (T+270)
1,936 shares
Common Stock
SEC:0001127602-21-015952·
1,936 shares
Common Stock
SEC:0001127602-21-015952:0·
€347,16220,282 shares@ €17.11680.0002% mcap50.0% of flow
Common Stock
SEC:0001127602-21-015340:0·
€347,16220,282 shares@ €17.11680.0002% mcap100.0% of flow
Common Stock
SEC:0001127602-21-015340·
9 of 9 declarations
About Whitley Richard James
Richard James Whitley is a Board Member at Gilead Sciences Inc and Virios Therapeutics, Inc. He has significant experience in the biopharmaceutical sector. As a board member, he is involved in overseeing operations and strategic decision-making. His expertise in life sciences is valuable in guiding these companies towards sustainable growth.
